Citation Impact
Citing Papers
Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer
2008
Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
2001 StandoutScience
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
2007 Standout
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress
2004 Standout
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
2005 StandoutScience
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
2009 StandoutNature
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Thiazolidinediones
2004 Standout
Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1
1999
Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus
2000 Standout
Identification of tissue transglutaminase as the autoantigen of celiac disease
1997 Standout
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
Cancer chemoprevention with dietary phytochemicals
2003 Standout
pp60v- Induction of Cyclin D1 Requires Collaborative Interactions between the Extracellular Signal-regulated Kinase, p38, and Jun Kinase Pathways
1999
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Signal integration by JNK and p38 MAPK pathways in cancer development
2009 Standout
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
2008 Standout
Smad transcription factors
2005 Standout
Thiazolidinediones: metabolic actions in vitro
2002
E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines
2006
New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes
2001
Transcriptional regulation by calcium, calcineurin, and NFAT
2003 Standout
Stat3 as an Oncogene
1999 Standout
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
2001 Standout
Peroxisome proliferator-activated receptor-γ ligands regulate endothelial membrane superoxide production
2005
Peroxisome Proliferator-activated Receptor γ Ligands Differentially Modulate Muscle Cell Differentiation and MyoD Gene Expression via Peroxisome Proliferator-activated Receptor γ-dependent and -independent Pathways
2001
Diabetic KKAy mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones
2001
Transcriptional cross-talk, the second mode of steroid hormone receptor action
1998
PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?
2003
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
2015 Standout
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
2002 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
PPARγ and the Treatment of Insulin Resistance
2000
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
FGF-21 as a novel metabolic regulator
2005 Standout
Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists
2000
The promise of retinoids to fight against cancer
2001
Polycystic Ovary Syndrome
2005 Standout
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Stat3 enhances vimentin gene expression by binding to the antisilencer element and interacting with the repressor protein, ZBP-89
2004
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Inflammation in atherosclerosis
2002 StandoutNature
Induction of ΔFosB in the Periaqueductal Gray by Stress Promotes Active Coping Responses
2007
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
2007 Standout
The Androgen Receptor Represses Transforming Growth Factor-β Signaling through Interaction with Smad3
2002
Adipocyte differentiation from the inside out
2006 Standout
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
2004 Standout
A single element in the phosphoenolpyruvate carboxykinase gene mediates thiazolidinedione action specifically in adipocytes
2001
Transcriptional regulation by the phosphorylation-dependent factor CREB
2001 Standout
Effect of Antioxidants on Androgen-Induced AP-1 and NF- B DNA-Binding Activity in Prostate Carcinoma Cells
1999
The molecular neurobiology of depression
2008 StandoutNature
The Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling Pathways
2002
AMPK: a nutrient and energy sensor that maintains energy homeostasis
2012 Standout
Multiple Functions of Jab1 Are Required for Early Embryonic Development and Growth Potential in Mice
2004 StandoutNobel
Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones
2000
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Roles of PPARs in health and disease
2000 StandoutNature
Tissue Transglutaminase: A Candidate Effector Element of Physiological Cell Death
1995
Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation
2011
Obesity and insulin resistance
2000 Standout
Androgen and Glucocorticoid Receptor Heterodimer Formation
1997
Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-κB, Activator Protein-1, and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation
2000 Standout
Peroxisome Proliferator–Activated Receptor γ and Metabolic Disease
2001
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
2006 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Troglitazone: A Possible Modulator of Ovarian Steroidogenesis
2002
Ligand-Activated Retinoic Acid Receptor Inhibits AP-1 Transactivation by Disrupting c-Jun/c-Fos Dimerization
1999
A Prospective, Randomized Comparison of the Metabolic Effects of Pioglitazone or Rosiglitazone in Patients With Type 2 Diabetes Who Were Previously Treated With Troglitazone
2002
Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells.
2001
Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo.
2003
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 Standout
Myostatin Inhibits Myoblast Differentiation by Down-regulating MyoD Expression
2002 Standout
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Activation of an adipogenic program in adult myoblasts with age
2002
Effects of Rosiglitazone on Lipids, Adipokines, and Inflammatory Markers in Nondiabetic Patients With Low High-Density Lipoprotein Cholesterol and Metabolic Syndrome
2005
Pathophysiology and Pharmacological Treatment of Insulin Resistance*
2000
Requirement for Transcription Factor NFAT in Interleukin-2 Expression
1999
Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
2003
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
2006 StandoutScience
Works of Scott Wise being referenced
The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors
2017
c-Jun Can Mediate Androgen Receptor-induced Transactivation
1996
AXL regulates mesothelioma proliferation and invasiveness
2010
cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype
1999
Identification of domains of c-Jun mediating androgen receptor transactivation
1998
Abstract 535: Preclinical use of focal radiation and immune checkpoint blockade to improve therapeutic response in an immunologically cold tumor
2019
Dominant-negative mutants of cJun inhibit AP-1 activity through multiple mechanisms and with different potencies.
1996
Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma.
1999
Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.
2000